Genevant Sciences

Industry

  • Biotechnology
    • Nanotechnology, Chips, etc.
    • Gene Therapy, Cell Therapy
    • Antisense, Oligonucleotides
    • Drug Discovery Technologies
      • Genomics-Proteomics
  • Pharmaceuticals
    • Drug Delivery
See more in Biomedtracker

Latest on Genevant Sciences

Scrip

Deal Watch: MacroGenics Offloads Margenza To TerSera As Focus Shifts To Pipeline

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. MacroGenics Gets $40m Up Front For St

Scrip

Deal Watch: Shionogi Will Market Nxera’s Insomnia Drug In Japan

 
• By Joseph Haas, Lisa Takagi, Vibha Ravi, and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Shionogi Gets Daridorexant’s Japanese D

Scrip

Deal Watch: Ikena Cuts Staff After BMS Exits IO Partnership

 
• By Joseph Haas and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Ikena Cuts Back As BMS Unravels Partner

Scrip

Deal Watch: Graphite Exits Via Reverse Merger With Presbyopia Specialist LENZ

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lenz/Graphite Combination Is All-Stock